New clinical trial registered for Bortezomib

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant (NCT05623020) registered on ClinicalTrials.gov. Phase: phase 3. Status: recruiting.